Stocktoria

ORTHOPEDIATRICS CORP KIDS

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2017-10-12

ORTHOPEDIATRICS CORP financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$236.3M$204.7M$148.7M$122.3M$98.0M
Gross profit$172.7M$148.6M$111.3M$90.7M$73.4M
R&D expense$9.1M$11.0M$10.9M$8.5M$5.5M
Operating income-$39.2M-$35.0M-$26.8M-$25.4M-$18.0M
Income tax$460,000-$4.1M-$338,000-$4.9M-$1.1M
Net income-$39.6M-$37.8M-$21.0M$1.3M-$16.3M
EPS (diluted)$-1.69$-1.64$-0.92$0.06$-0.84
Operating cash flow-$4.9M-$27.0M-$27.0M-$21.8M-$13.1M
Free cash flow-$16.0M-$41.3M-$43.9M-$31.8M-$21.2M
Cash & equivalents$19.6M$43.8M$31.1M$9.0M$7.6M
Inventory$133.8M$117.0M$105.9M$78.2M$57.6M
Total assets$508.6M$473.2M$438.7M$427.7M$304.3M
Total liabilities$162.0M$118.6M$61.7M$49.1M$78.9M
Shareholders' equity$346.6M$354.6M$377.0M$378.6M$225.4M

Source: SEC EDGAR filings · CIK 0001425450 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.